YIV-906

N/A

Report date: 2026/05/12 20:00:17

Base Information

Drug NameYIV-906
Drug Alias NamePowdered extracts of the herbs Scutellaria baicalensis Geori, Glycyrrhiza uralensis Fisch, Paeonia lactiflora Pall, and Ziziphus jujuba MillKD-018PHY-906
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsWnt signalling pathway modulatorsCyclooxygenase-2 inhibitors +[8] 
TargetsAcetylcholinesteraseNuclear factor NF-kappa-B complexCyclooxygenase-2 +[6] 
Therapy Area/IndicationsDiarrheaPancreatic NeoplasmsLiver Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanHong Kong +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPhytoceutica Inc
China Registration ClassN/A

Develop Information

Active CompaniesYiviva Inc
Inactive CompaniesYale UniversityNational Cancer InstitutePhytoceutica Inc +[4] 
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsDiarrheaPancreatic NeoplasmsLiver Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A